Company Statement: Alfred E. Mann restructures by selling pharmaceutical entity MannKind to The Mann Group
MLex Summary: Alfred E. Mann has restructured his holdings by selling his pharmaceutical company MannKind to the Mann Group for $77.2 million. The deal is expected to close following regulatory and shareholder approval....To view the full article, register now.
Already a subscriber? Click here to view full article